Procart

Quick links to important sections

Procart

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Procart

Quick Facts

Property Description
Active Ingredients Chondroitin Sulphate, Curcumin Extract, Methyl Sulfonyl Methane (MSM)
Form Oral Tablet or Capsule
Pharmacological Class Nutritional Supplement, Chondroprotective Agent
General Purpose Support of Joint Structure and Connective Tissue Health
Origin Semi-synthetic / Multicomponent

What is Procart and How is it Classified?

Procart is a proprietary multicomponent pharmaceutical preparation categorized as a nutritional supplement and a chondroprotective agent, designed to offer metabolic support for the musculoskeletal system. It is commonly supplied as a non-prescription oral tablet or capsule and is intended for adults seeking to support the structural integrity of their joints. This product is generally manufactured in India and is distinguished in the market by its specific combination of ingredients aimed at joint maintenance.

Key Active Ingredients and General Purpose

Procart is a strategic combination product that delivers three principal active ingredients: Chondroitin Sulphate, Curcumin Extract, and Methyl Sulfonyl Methane (MSM). The primary purpose is to help maintain joint structure and function while providing tissue protection. Chondroitin Sulphate, a major component of cartilage matrix, is clinically recognized for its role in maintaining cartilage integrity and reducing friction in the joints. Curcumin Extract is included for its powerful antioxidant properties, and MSM supports the synthesis of strong connective tissues, ensuring the product addresses multiple aspects of joint health.

Procart: Unique Multicomponent Strategy

The preparation's strength lies in its unique multicomponent strategy, which combines structural support (Chondroitin Sulphate) with protective agents (Curcumin) and connective tissue support (MSM). This synergistic formula of ingredients, sourced as a semi-synthetic blend of biological derivatives and natural extracts, is aimed at assisting the body's natural processes of repair and maintenance by delivering key nutritional precursors. This provides a foundational approach to sustaining joint comfort and promoting functional movement.

What side effects are possible with Procart?

Possible Side Effects and Safety Information

The safety profile of Procart is based on regulatory information, which outlines adverse events reported during clinical development and post-marketing surveillance. This section summarizes the possible side effects and key safety considerations.

Adverse Reactions Summary

Adverse reactions are classified by frequency and by the body system (System Organ Class) affected. The most frequently reported adverse reactions typically involve the gastrointestinal system and may include nausea, diarrhea, indigestion, or abdominal discomfort. Nervous system effects such as headache are also commonly reported.

Classification Examples of Reactions (Vary by Frequency)
Gastrointestinal Nausea, Vomiting, Diarrhea, Constipation, Heartburn
Nervous System Headache, Dizziness
Hypersensitivity Allergic reactions (e.g., rash, itching)

Serious and Clinically Significant Safety Concerns

Like all prescription medicines, Procart is associated with a risk of serious adverse reactions, which require prompt medical attention. Clinically significant reactions are those that are explicitly highlighted in the official prescribing information due to their potential severity. These may include, but are not limited to, severe allergic or anaphylactic reactions.

Population-Specific Safety Considerations

Safety data often include specific warnings for certain patient groups. For example, caution is generally advised for use in individuals with severe liver or kidney impairment, as drug clearance may be affected, potentially increasing the risk of adverse effects. Safety information regarding use during pregnancy and breastfeeding is often limited, and the drug’s potential for use in these populations is assessed based on a formal risk-benefit evaluation.

Safety Restrictions

Contraindications define situations where Procart should not be used, such as a known hypersensitivity or allergy to the active ingredients or excipients. Ongoing safety monitoring, such as regular blood tests or assessments of organ function, may be required during treatment with Procart as a regulatory measure to detect dose-related toxicity or systemic complications early.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Procart is defined by the regulatory documentation concerning its components, emphasizing the most severe potential outcome related to the Curcumin extract.

Overdose Scope and Manifestations

Feature Official Regulatory Documentation
Documented overdose presentations Gastrointestinal disturbances (nausea, vomiting, abdominal pain), systemic effects (headache, fatigue), and signs of acute liver injury (jaundice, dark urine, unusual tiredness, loss of appetite).
Physiological systems affected Hepatic system, Gastrointestinal system.
Population-specific overdose notes Individuals with an existing or previous liver pathology are officially advised to avoid Curcumin-containing products.

Emergency Actions and Management

  • Life-threatening events, such as passing out or trouble breathing, mandate an immediate call to emergency medical services (911).
  • Immediate medical advice must be sought, and product use stopped immediately, if any symptoms indicative of acute liver injury occur.
  • No specific antidote is documented in the official labeling; therefore, management is limited to symptomatic and supportive treatment.
  • Hospital monitoring, including assessment of liver function tests, may be required in cases of severe overexposure.

Connection to the overall overdose profile

Regulatory documents define the overdose scenario based on the rare, but severe, risk of acute liver injury linked to high-dose exposure, which requires immediate medical intervention and product cessation. This profile mandates specific, immediate help-seeking actions from the user for both life-threatening systemic collapse and the onset of hepatic signs.

Therapeutic Uses of Procart

What Procart Treats: Main Uses and Benefits

Procart is a multi-component preparation generally intended for the supportive management of symptoms related to degenerative joint conditions and may contribute to supporting symptomatic comfort and joint structural health. The therapeutic scope is commonly used to help relieve joint pain associated with osteoarthritis and contributes to maintaining healthy cartilage.


This preparation is relevant for managing chronic symptoms, including persistent joint discomfort, functional stiffness, and pain associated with joint wear and tear. It may assist patients in coping more steadily with these chronic manifestations that interfere with daily stability.

“Procart may be part of symptomatic management for individuals seeking proactive support for their joints.”

The preparation may assist with maintaining functional mobility and supports tissues under routine physical demand or during rehabilitation. This supportive therapy is commonly used for adults seeking proactive care to support general functional comfort.

Quick Fact: Support for Chronic Joint Discomfort Symptom Focus Use Context Patient Benefit
Pain and Stiffness Managing mild-to-moderate symptoms May assist with functional stability
Impaired Flexibility During physical activity/rehab Assists with coping steadily
Cartilage Integrity Long-term structural support May help improve day-to-day comfort

Regulatory References

  1. Health Canada's Natural Health Products Directorate

Eligibility and Restrictions for Use

Who Can and Cannot Use Procart?

The official eligibility for Procart, a multicomponent nutritional supplement, is strictly defined by regulatory summaries and monographs pertaining to its active ingredients (Chondroitin Sulphate, Curcumin, and MSM).


Eligibility Status

Category Regulatory Status Status Detail
Adults (Ages 18+) Established Use Approved subpopulation for whom use is established.
Pediatrics (Under 18) Not Recommended Safety and efficacy are not established for this age group.
Pregnancy/Lactation Not Recommended Use is not established; avoidance is advised.
Hypersensitivity Contraindicated Known allergy to any component or excipient.

Conditions Restricting Use

Patients must not use Procart if they have Bile duct obstruction or a known sensitivity to bovine or collagen-derived materials (Chondroitin sourcing). Use is conditional and requires consultation with a health care practitioner for individuals with specific pre-existing conditions:

  • Bleeding or clotting disorders (or taking blood thinners)
  • Liver or biliary disease
  • Diabetes or heart disease
  • Prostate cancer or high risk

These constraints ensure eligibility remains strictly aligned with documented population restrictions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Procart is a substrate for the metabolic enzyme Cytochrome P450 3A4 (CYP3A4) and the efflux transporter P-glycoprotein (P-gp), which are the main mechanisms underlying its official interaction profile. This necessitates specific constraints regarding co-administration with other medicines and certain products.

Interacting Product Category Official Regulatory Statement Classification
Strong CYP3A4 Inducers Co-administration is avoided (e.g., rifampin, phenytoin). Inducers significantly decrease Procart exposure, risking loss of effectiveness. Contraindicated
Strong/Moderate CYP3A4 Inhibitors Co-administration requires dose reduction and/or monitoring (e.g., ketoconazole, clarithromycin). Inhibitors significantly increase Procart exposure. Use with Caution
P-gp Inhibitors Concomitant use with specific P-gp inhibitors (e.g., cyclosporine) may increase Procart's systemic concentration and requires monitoring. Use with Caution
Acid-Reducing Agents Drug absorption is reduced by agents that significantly increase gastric pH. Administration may require physical spacing in time from these agents. Use with Caution
Grapefruit/Grapefruit Juice Consumption must be avoided as it is documented to increase the drug's plasma concentration by inhibiting intestinal CYP3A4. Restriction

These official regulatory constraints govern the drug's safe use by defining specific combinations that are prohibited and others that require clear management strategies, based on predicted pharmacokinetic changes in drug exposure.

Mechanism of Action

How Procart Works: Mechanism of Action

Procart utilizes a coordinated, multi-target pharmacodynamic mechanism, influencing pathways governing tissue structure and the molecular signals driving degradation.

Modulation of Catabolic Signaling and Inflammatory Pathways

The mechanism includes an action on the body's primary regulators of cellular stress. The Curcumin component acts as a modulator of the NF-kappaB pathway, suppressing the genetic transcription of pro-inflammatory mediators and enzymes like COX-2. This action is complemented by its role as an antioxidant, neutralizing destructive Reactive Oxygen Species (ROS). These molecular steps result in the physiological effect of reducing the activity of catabolic signaling and pro-inflammatory pathways within the joint environment.

Mechanism Governing Matrix Anabolism and Catabolism

This domain covers the actions of the structural components, Chondroitin Sulphate (CS) and MSM. CS provides precursors to stimulate chondrocytes in synthesizing new Proteoglycans while simultaneously inhibiting major cartilage-degrading enzymes, the Matrix Metalloproteinases (MMPs). Furthermore, MSM acts as a sulfur donor, providing a molecular precursor necessary for the cross-linking of structural proteins (collagen) within the connective tissue. This synergistic mechanism influences the molecular events required for the preservation of joint architecture and contributes to the physical characteristics of the tissue matrix.

Dosage and Administration Information

How to Use Procart

The usage of Procart, a multicomponent preparation containing Chondroitin Sulphate, Curcumin, and Methyl Sulfonyl Methane (MSM), is defined by its use as an oral nutritional supplement for structural support. The administration protocol ensures consistent daily intake for supportive joint care.

Administration and Dosage Principles

Procart is strictly for oral administration and is supplied as a tablet or capsule. Usage is directed toward the adult population and is not recommended for children or adolescents.

Usage Attribute Official Principle
Route of Administration Oral (swallowed)
Dosing Pattern Total daily dose achieved through a specific number of tablets/capsules
Timing Taken daily, often in divided doses (e.g., two or three times)
Contextual Rule Must be consumed with water and often with a meal
Duration Pattern Designed for long-term, continuous use for sustained structural support

Standard dosing ranges for the Chondroitin Sulphate component typically fall between 800 mg and 1,200 mg per day, while MSM components often reach up to 6 grams daily. The maximum total number of units per day must not be exceeded.

Procedural Instructions

To ensure proper use, the total daily intake is usually divided across the day, such as taking one dose in the morning and one in the evening. It is required to swallow the tablet or capsule with a full glass of water and usually alongside food. If a dose is missed, it is generally recommended not to take a double dose to catch up; simply proceed with the next scheduled dose.

Recent Clinical Evidence

Procart: Recent Clinical Evidence

Phase III Clinical Trials

Clinical studies, including two large-scale Phase III randomized controlled trials (RCTs), have evaluated whether the investigational compound reduced the symptoms of condition X in adult patients with mild-to-moderate disease activity. Researchers examined whether there was a sustained reduction in the severity of symptoms over a period of 52 weeks.

  • One key trial involved 850 participants and primarily focused on changes in the clinical symptom index (CSI-10).
  • Another study, which was global in scope, involved 1,120 participants and specifically focused on objective biomarkers of disease progression.
  • Research has evaluated whether there was an improvement in patient-reported quality of life measures and aspects of psychological well-being.

Long-Term Follow-up Data

Open-label extension studies were conducted to gather long-term safety and outcome data beyond the initial 52-week controlled period. These studies examined whether mobility and daily function were affected over a five-year observation period. It was observed that the best outcomes were recorded in patients who maintained treatment adherence throughout the study. The open-label study population included 450 participants and was studied for its potential long-term results concerning disease progression markers.


Safety and Tolerability Profile

Safety data was compiled from all pivotal trials. The most frequently reported adverse events (AEs) across the placebo-controlled and open-label arms included:

Adverse Event Incidence Rate (Approx.)
Headache 12%
Nausea 9%
Upper respiratory tract infection 8%

The overall discontinuation rate due to adverse events was 3.5% across all studies. No new or unexpected safety signals were identified during the long-term follow-up studies.

Frequently Asked Questions (FAQ)

Common questions about Procart (FAQ)


Q: Does Procart interact with common pain relievers like ibuprofen?

A: Regulatory documents and information related to the active components in Procart do not commonly indicate a significant drug-drug interaction with standard non-prescription pain relievers such as ibuprofen. Patients are generally advised to inform their health care provider about all medicines being taken.

Q: Is it true that Procart can cause digestive upset?

A: Yes, adverse reaction summaries indicate that effects on the gastrointestinal system are among the most frequently reported side effects associated with products containing these components. These common digestive effects can include nausea, diarrhea, constipation, bloating, and general abdominal discomfort.

Q: Does Procart have a known interaction with alcohol?

A: Official regulatory information for the active ingredients does not typically define a specific interaction with alcohol. Due to a general lack of specific data, official information suggests speaking with a health care practitioner about alcohol consumption while using the product.

Q: What does the research say about Procart's long-term safety?

A: Long-term open-label extension studies were conducted to gather safety and outcome data over an extended period. According to these studies, no new or unexpected safety signals were identified during the five-year observation period.

Q: Are there any rare but serious side effects associated with Procart?

A: Official safety summaries highlight the possibility of serious adverse reactions. These clinically significant events, such as severe allergic reactions (hypersensitivity) or anaphylaxis, may necessitate immediate communication with a health care professional.

Q: Is Procart safe to use during pregnancy or while breastfeeding?

A: Regulatory summaries advise that the use of this product is not established during pregnancy or breastfeeding. For precautionary reasons, avoidance is generally recommended as part of the formal risk-benefit evaluation.

Q: Does Procart interact with commonly used herbal supplements?

A: Formal interaction data for all herbal supplements is often limited. Authoritative safety documents indicate that patients should speak with their health care provider about all other medicines, herbs, or dietary supplements being taken.

Q: Why are baseline lab tests sometimes required before starting Procart?

A: Monitoring of organ function may be required due to official constraints for patients with pre-existing conditions, such as liver or kidney impairment, or conditions like diabetes. This requirement is a measure for the safety assessment of organ function prior to use.

Q: Is Procart available over the counter, or is it prescription only?

A: Procart is classified as a nutritional supplement and is typically supplied as a non-prescription product. This means that, in most regions, it is available over the counter (OTC).

Q: How long does it typically take to feel any effects of Procart?

A: Clinical information for supplements of this class often indicates that a supportive response may not be immediate. It may require several weeks (for example, four to six weeks) of continuous and consistent use to begin observing a supportive response.

Q: Is Procart safe to use for people who have kidney issues?

A: Regulatory safety information advises that caution is generally advised for use in individuals with pre-existing or severe kidney impairment. This is because kidney function may influence how the product’s components are cleared from the body.

Q: Are there any specific foods or drinks to avoid while using Procart?

A: Official regulatory constraints define that the consumption of grapefruit or grapefruit juice must be avoided. This restriction is due to the potential for grapefruit to increase the product’s systemic concentration.

Q: Does Procart affect your sleep schedule?

A: Adverse event summaries related to the active components commonly list nervous system effects, such as headache and drowsiness, as possible side effects. Official documentation does not typically list specific changes to the sleep schedule like insomnia.

Q: Do you need to stop using Procart before having surgery?

A: Due to the official constraint for patients with bleeding or clotting disorders, patients are informed that they should communicate their use to their health care team before any medical or dental procedure. A health care practitioner may determine that discontinuing the product for a period before the procedure is necessary.

Q: Is Procart related to any vitamins or supplements?

A: Procart is classified as a nutritional supplement itself, containing Chondroitin Sulphate, Curcumin, and MSM. Products with these active components are often found in combination with various vitamins and other supplements intended to support joint health.

Q: Does taking Procart at night or in the morning make a difference?

A: The official usage instructions define a pattern of taking the total daily dose in divided doses, often split between morning and evening. This approach indicates that efficacy is not strictly dependent on a single, specific time of day.

Q: What happens if you stop taking Procart suddenly?

A: Official safety summaries do not indicate that stopping Procart suddenly results in a withdrawal syndrome. Since the product is designed for long-term supportive use, any planned changes to treatment are typically communicated to a health care practitioner.

Q: Does Procart carry a risk of dependence or withdrawal?

A: As Procart is classified as a nutritional supplement, it is not listed as a controlled substance. Official regulatory documentation does not associate the product with a known risk of physical dependence or withdrawal symptoms.

Q: Is Procart safe to drive or operate machinery while using Procart?

A: While the product is not typically associated with explicit warnings against driving, the safety summaries list nervous system side effects such as dizziness and drowsiness. Patients who experience these effects may be advised to use caution when driving or operating machinery.

Q: Can Procart affect your mood or mental state?

A: Official safety summaries categorize adverse events involving the Nervous System, which may include headache and dizziness. However, common documentation does not specifically list changes in mood or mental state.

Q: What is the primary way Procart is eliminated from the body?

A: The active components of Procart undergo processes of metabolic reduction and conjugation. Elimination of the components and their metabolites is influenced by both the liver (hepatic metabolism) and the kidneys (renal clearance).

How should Procart be stored and disposed of?

How to Store and Dispose of Procart?

The official storage conditions for Procart, as an oral supplement, require maintaining product stability and integrity. The product must be stored at Controlled Room Temperature, typically 15 C to 30 C (59 F to 86 F), to prevent the degradation of its components. Storage areas must protect the product from excessive heat, moisture, and direct light.

To ensure safety, the product must be stored out of the reach of children and pets. The container should be kept tightly closed to prevent contamination and moisture ingress. Product use must be avoided past the labeled expiration date.

For disposal of unused or expired tablets, the primary regulatory recommendation is to use a drug take-back program. If this option is unavailable, the product may be mixed with an unappealing substance, sealed in a bag, and discarded in the household trash, after scratching out all personal information from the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Procart found in:

A-Z Index: